Raymond James Downgrades Adverum Biotechnologies (ADVM) to Underperform
Tweet
Share
E-mailGet Alerts ADVM Hot Sheet
Price: $4.36 --0%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Raymond James analyst Dane Leone downgraded Adverum Biotechnologies (NASDAQ: ADVM) from Market Perform to Underperform.
For an analyst ratings summary and ratings history on Adverum Biotechnologies click here. For more ratings news on Adverum Biotechnologies click here.
Shares of Adverum Biotechnologies closed at $23.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- RBC Capital Downgrades CareTrust REIT (CTRE) to Sector Perform
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
